Future Journal of Pharmaceutical Sciences

Table 3 Result of system precision

From: Development and validation of stability-indicating UPLC method for the determination of gliclazide and its impurities in pharmaceutical dosage forms

Injection number	Peak area
1	3417135
2	3437162
3	3381424
4	3370534
5	3370306
6	3373095
Average	3391609.333
SD	28534.63979
% RSD	0.84

Back to article page